ECO 2026: New Consensus Guidance Issued for Incretin-Based Obesity Treatment Tags GLP-1 agonists Read more about ECO 2026: New Consensus Guidance Issued for Incretin-Based Obesity Treatment
ECO 2026: GLP-1-Based Obesity Therapy Reduced Fat More Than Muscle Mass Tags GLP-1 agonists Read more about ECO 2026: GLP-1-Based Obesity Therapy Reduced Fat More Than Muscle Mass
ECO 2026: Semaglutide Reduced BMI in Severe Youth Obesity Tags GLP-1 agonists Read more about ECO 2026: Semaglutide Reduced BMI in Severe Youth Obesity
ECO2026: Continued Tirzepatide Therapy Preserves Weight Loss Tags GLP-1 agonists Read more about ECO2026: Continued Tirzepatide Therapy Preserves Weight Loss
ECO 2026: Oral Orforglipron Maintains Weight Loss After GLP-1 Switch Tags GLP-1 agonists Read more about ECO 2026: Oral Orforglipron Maintains Weight Loss After GLP-1 Switch
ECO 2026: EASO Updates Obesity Drug Guidance Algorithm Tags GLP-1 agonists Read more about ECO 2026: EASO Updates Obesity Drug Guidance Algorithm
Estimated Oral Semaglutide Exposure Linked to Weight Loss and GI Side Effects Tags GLP-1 agonists Read more about Estimated Oral Semaglutide Exposure Linked to Weight Loss and GI Side Effects
GLP-1 RAs Linked to Lower Mortality in Breast Cancer Tags GLP-1 agonists Read more about GLP-1 RAs Linked to Lower Mortality in Breast Cancer
MACE Rates With Semaglutide Were Similar Across Weight Loss Strata Tags GLP-1 agonists Read more about MACE Rates With Semaglutide Were Similar Across Weight Loss Strata
GLP-1 Therapy Lowered MACE and Hypoglycemia Risk in T1DM Tags Coronary artery disease Myocardial infarction GLP-1 agonists Read more about GLP-1 Therapy Lowered MACE and Hypoglycemia Risk in T1DM